Right-sided Colon CancerNCT07350590
Comparison Between Robotic and Laparoscopic Right Hemicolectomy
An observational study of Right-sided Colon Cancer, run by Sir Run Run Shaw Hospital at 1 site in China.
Trial summary
This study aims to compare outcomes of robotic versus laparoscopic right hemicolectomy for right colon cancer. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Right-sided Colon Cancer
- What is being tested?
- laparoscopic right hemicolectomy and robotic right hemicolectomy
- Type of treatment
- Surgery or procedure
- How many people
- 771 participants
- Where
- 1 siteChina
- Study dates
- 1 Mar 2026to 28 Mar 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: right colon cancer patients
Who may be able to join
- colon cancer lesions to be located at the hepatic flexure, ascending colon, or cecum, as confirmed by colonoscopy
- the pathological biopsy revealed adenocarcinoma, and the clinical staging was diagnosed as clinical stages I to IV according to the American Joint Committee on Cancer (AJCC) TNM classification (8th edition)
- the patients plan to undergo right hemicolectomy
- the Eastern Cooperative Oncology Group Performance Status (ECOG-PS) is 0 or 1
Who cannot join
- incomplete case data
- surgery performed after colorectal cancer recurrence
- patients with multiple primary cancers and other malignant tumors.
Trial locations and contacts
1 site in 1 country.
China1 site
Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000
About this study
Official title: Short- and Long-Term Outcomes of Robotic vs. Laparoscopic Right Hemicolectomy: A Multicenter Retrospective Study
This study aims to compare outcomes of robotic versus laparoscopic right hemicolectomy for right colon cancer.
- Conditions
- Right-sided Colon Cancer
- Being tested
- laparoscopic right hemicolectomy, robotic right hemicolectomy
- Keywords
- right-sided colon cancer, robotic surgery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
laparoscopic right hemicolectomyProcedure or surgery
laparoscopic right hemicolectomy
robotic right hemicolectomyProcedure or surgery
robotic right hemicolectomy
| Study group | Role | What they receive |
|---|---|---|
| laparoscopic right hemicolectomy | Not described Receives: Procedure: laparoscopic right hemicolectomy | |
| robotic right hemicolectomy | Not described Receives: Procedure: robotic right hemicolectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Disease free survival(DFS)
The three-year disease-free survival of patients.
Measured: 3 years after surgery
Secondary outcomes (4)
Overall survival(OS）
The three-year overall survival of patients.
Measured: 3 years after surgery
Surgical complications
During the perioperative period, the incidence of surgical complications
Measured: During the perioperative period
Surgical recovery time
It refers to the time required for patients to resume gas passing, bowel movements, be discharged from the hospital, and return to normal life after surgery
Measured: During the perioperative period
Hospitalization expenses
Hospitalization expenses include surgery-related costs
Measured: During the perioperative period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jan 2026
- Study start1 Mar 2026
- Primary completion1 Mar 2026
- Study completion28 Mar 2026
Why it stopped: have Plan B
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Right-sided Colon CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 771 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sir Run Run Shaw Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zhangfa Song, Sir Run Run Shaw Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07350590
- Sponsor's protocol ID
- LRCRC
- Status last verified
- Mar 2026
- First submitted
- 3 Jan 2026
- Last updated
- 2 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Short- and Long-Term Outcomes of Robotic vs. Laparoscopic Right Hemicolectomy: A Multicenter Retrospective Study
- ClinicalTrials.gov ID
- NCT07350590
- Acronym / sponsor ID
- LRCRC
- Conditions
- Right-sided Colon Cancer
- Keywords
- right-sided colon cancer, robotic surgery
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: have Plan B
- Enrolment
- 771 participants (actual)
- Lead sponsor
- Sir Run Run Shaw HospitalUniversity, hospital or other
- Study start
- 1 Mar 2026 (actual)
- Primary completion
- 1 Mar 2026 (actual)
- Study completion
- 28 Mar 2026 (actual)
- First posted
- 20 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare outcomes of robotic versus laparoscopic right hemicolectomy for right colon cancer.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| laparoscopic right hemicolectomy | – | Procedure: laparoscopic right hemicolectomy |
| robotic right hemicolectomy | – | Procedure: robotic right hemicolectomy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- right colon cancer patients
Key inclusion criteria (4 listed)
- colon cancer lesions to be located at the hepatic flexure, ascending colon, or cecum, as confirmed by colonoscopy
- the pathological biopsy revealed adenocarcinoma, and the clinical staging was diagnosed as clinical stages I to IV according to the American Joint Committee on Cancer (AJCC) TNM classification (8th edition)
- the patients plan to undergo right hemicolectomy
- the Eastern Cooperative Oncology Group Performance Status (ECOG-PS) is 0 or 1
Key exclusion criteria (3 listed)
- incomplete case data
- surgery performed after colorectal cancer recurrence
- patients with multiple primary cancers and other malignant tumors.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| laparoscopic right hemicolectomylaparoscopic right hemicolectomy | Procedure or surgery | laparoscopic right hemicolectomy |
| robotic right hemicolectomyrobotic right hemicolectomy | Procedure or surgery | robotic right hemicolectomy |
Primary outcome
Disease free survival(DFS)
Time frame: 3 years after surgery
The three-year disease-free survival of patients.
4 secondary outcomes
Overall survival(OS）
Time frame: 3 years after surgery
Surgical complications
Time frame: During the perioperative period
Surgical recovery time
Time frame: During the perioperative period
Hospitalization expenses
Time frame: During the perioperative period
Results and safety
The study was stopped early (reason given: have Plan B). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Right-sided Colon Cancer
RecruitingPhase 2
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Colorectal Cancer (CRC)
Active, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Colon Cancer, Colon Polyp
RecruitingObservational study
Mesogastrium Metastasis in Colon Cancer
Colon Cancer
Not yet recruitingObservational study
Multicenter Prospective Study Protocol for Validating Surgical Quality Standards in D3 Lymphadenectomy for Oncological Right Hemicolectomy
Colon Neoplasms, Right Colon Tumors
Not yet recruiting
Right Colon Enema to Improve Bowel Preparation Quality During Colonoscopy
Colonic Polyps, Colorectal Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Right-sided Colon Cancer, run by Sir Run Run Shaw Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: have Plan B). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Disease free survival(DFS) (time frame: 3 years after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.